Search academic texts

Information × Registration Number 0306U001960, 0105U002537 , R & D reports Title CT-2103 vs. germcitabine or vinorelbine for the treatment of PS=2 patients with chemotherapy naїve advanced non - small cell lung cancer (NSCLC): a phase III study. popup.stage_title Дослідження препарату СТ-2103 у хворих з місцево розповсюдженим та метастатичним недрібноклітинним раком легень. Head Hotko Evgen Stepanovych, Registration Date 01-09-2006 Organization Uzhgorod National University popup.description2 By results of the work (analysis of a survival rate, the time before progression of disease) is demonstrated, that the explored drug (СТ-2103) would not yield gemcitabine at treatment patients with IIIB - IV by stages of a NSCLC. Besides the toxic developments at application СТ-2103 did not exceed neither on frequency, not on a degree of manifestation those at application gemcitabine5635563556355635 Product Description popup.authors popup.nrat_date 2020-04-02 Close